Literature DB >> 2695275

Regulation of protein kinase C by sphingosine and lysosphingolipids.

Y A Hannun1, R M Bell.   

Abstract

Protein kinase C (PKC), a calcium and phospholipid dependent protein kinase C, has emerged as a key element in signal transduction and cell regulation. It is activated by sn-1,2-diacylglycerol (DAG) second messengers and it serves as the receptor for phorbol esters, potent tumor promoters. PKC is now known to occur as a family of isoenzymes sharing similar structural features that allow regulation of activity by calcium, phospholipid, and DAG. In vitro mechanisms of PKC regulation by phospholipid, DAG, and phorbol esters have been studied using mixed micelles of Triton X-100/lipids. PKC activation occurs at physiologic mole fractions of phospholipid and DAG, does not require a bilayer, and appears to occur by a two-step mechanism whereby PKC initially interacts with a phospholipid surface and is then activated by the addition of DAG. Similar methodology has been used to explore the inhibition of PKC by different inhibitors that interact with its regulatory domain. Sphingosine and lysosphingolipids are potent inhibitors of PKC that prevent its interaction with DAG/phorbol esters. These naturally occurring metabolites have been shown to affect PKC activity in different cell systems. Disturbances in sphingolipid metabolism may lead to accumulation of lysosphingolipids with consequent inhibition of PKC. Additionally, these naturally occurring metabolites may have physiologic functions in regulating PKC activity by counteracting the action of DAG. The mechanism of action of sphingosine/lysosphingolipids and their possible physiologic function will be discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2695275     DOI: 10.1016/0009-8981(89)90224-6

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  23 in total

1.  Modulation of protein kinase C by endogenous sphingosine: inhibition of phorbol dibutyrate binding in Niemann-Pick C fibroblasts.

Authors:  C Rodriguez-Lafrasse; R Rousson; S Valla; P Antignac; P Louisot; M T Vanier
Journal:  Biochem J       Date:  1997-08-01       Impact factor: 3.857

Review 2.  Lysosphingolipids and sphingolipidoses: Psychosine in Krabbe's disease.

Authors:  Stefka Spassieva; Erhard Bieberich
Journal:  J Neurosci Res       Date:  2016-11       Impact factor: 4.164

3.  The ATP-Binding Cassette Transporter-2 (ABCA2) Overexpression Modulates Sphingosine Levels and Transcription of the Amyloid Precursor Protein (APP) Gene.

Authors:  Warren Davis
Journal:  Curr Alzheimer Res       Date:  2015       Impact factor: 3.498

Review 4.  Membrane lipids and cell signaling.

Authors:  Hannah Sunshine; Maria Luisa Iruela-Arispe
Journal:  Curr Opin Lipidol       Date:  2017-10       Impact factor: 4.776

5.  SERCA2 dysfunction in Darier disease causes endoplasmic reticulum stress and impaired cell-to-cell adhesion strength: rescue by Miglustat.

Authors:  Magali Savignac; Marina Simon; Anissa Edir; Laure Guibbal; Alain Hovnanian
Journal:  J Invest Dermatol       Date:  2014-01-03       Impact factor: 8.551

6.  Sphingosine increases the permeability of model and cell membranes.

Authors:  F-Xabier Contreras; Jesús Sot; Alicia Alonso; Félix M Goñi
Journal:  Biophys J       Date:  2006-03-13       Impact factor: 4.033

7.  Ceramide signaling in cancer and stem cells.

Authors:  Erhard Bieberich
Journal:  Future Lipidol       Date:  2008-06

8.  Modulation of extracellular ATP-induced Ca2+ responses: role of protein kinases.

Authors:  L Tenneti; B R Talamo
Journal:  Biochem J       Date:  1993-10-01       Impact factor: 3.857

9.  Structural studies on the neutral glycosphingolipids of Manduca sexta.

Authors:  D Thusitha U Abeytunga; Lynne Oland; Arpad Somogyi; Robin Polt
Journal:  Bioorg Chem       Date:  2007-11-19       Impact factor: 5.275

Review 10.  Ceramidases: regulators of cellular responses mediated by ceramide, sphingosine, and sphingosine-1-phosphate.

Authors:  Cungui Mao; Lina M Obeid
Journal:  Biochim Biophys Acta       Date:  2008-06-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.